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Abstract
Background: Caenorhabditis elegans provides a genetically tractable model organism to investigate the network of
genes involved in fat metabolism and how regulation is perturbed to produce the complex phenotype of obesity.
C. elegans possess the full range of desaturases, including the Δ9 desaturases expressed by fat-5, fat-6 and fat-7.
They regulate the biosynthesis of monounsaturated fatty acids, used for the synthesis of lipids including
phospholipids, triglycerides and cholesteryl esters.
Results: Liquid chromatography mass spectrometry (LC-MS), gas chromatography mass spectrometry (GC-MS) and
nuclear magnetic resonance (NMR) spectroscopy were used to define the metabolome of all the possible knock-
outs for the Δ9 desaturases, including for the first time intact lipids. Despite the genes having similar enzymatic
roles, excellent discrimination was achievable for all single and viable double mutants highlighting the distinctive
roles of fat-6 and fat-7, both expressing steroyl-CoA desaturases. The metabolomic changes extend to aqueous
metabolites demonstrating the influence Δ9 desaturases have on regulating global metabolism and highlighting
how comprehensive metabolomics is more discriminatory than classically used dyes for fat staining.
Conclusions: The propagation of metabolic changes across the network of metabolism demonstrates that
modification of the Δ9 desaturases places C.elegans into a catabolic state compared with wildtype controls.
Background
Regulatory networks that govern fat and glucose metabo-
lism are optimized to expend carbohydrates and accumu-
late fat when food intake is abundant, and switch to the
consumption of stored fat when food is scarce. Even subtle
deregulation of these pathways can bring about obesity
[1,2], a significant risk factor for major diseases including
hypertension, diabetes, coronary heart disease, myocardial
infarction, liver disease and some cancers [3]. While obe-
sity is a multifactorial feature, studies on twin and adopted
children susceptibility to fat accumulation demonstrate
that genetic predisposition is a key contributing factor in
obesity [4-9]. Thus, it is important to understand how the
network of genes involved in fat metabolism exerts regula-
tion across the whole system to regulate fat synthesis and
storage.
The nematode Caenorhabditis elegans has become a
popular model for exploring the genetic basis for the regu-
lation of fatty acid synthesis and storage [10]. Although
worm and mammalian physiologies differ greatly, many
of the proteins involved in synthesizing, oxidising and
transporting fats, as well as many of the fat-regulatory
components are highly conserved between C. elegans and
mammals [11]. Furthermore, the genetic tractability of
C. elegans allows one to take a global perspective for a
complex trait such as the ability to store fat. A systematic
RNAi screen of the C. elegans genome identified 305
genes associated with reduced body fat and 112 gene asso-
ciated with increased fat storage [12] providing a powerful
tool for the modelling of fat metabolism at the whole
organism level. Because of the complexity of metabolic
regulation, a genetically tractable system like C. elegans
offers exceptional potential to unravel the connections
across the genome that regulate fat metabolism and have
led to the discovery of mammalian genes involved in
energy balance [13,14].
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C. elegans expresses the full range of desaturases activ-
ities found in plants (Δ12 and ω3 desaturase) and animals
(Δ5, Δ6 and Δ9 desaturase) [15]. The Δ9 desaturases are
the rate limiting enzymes in the biosynthesis of monoun-
saturated fatty acids which are used as preferred substrates
for the synthesis of various kinds of lipids including phos-
pholipids, triglycerides and cholesteryl esters. The crucial
role of these enzymes arises because unsaturation of a
fatty acid chain is a major determinant of the melting tem-
perature of triglycerides, as well as the fluidity of biological
membranes [16]. As a key control point in metabolic regu-
lation, Δ9 has been proposed as a therapeutic target for
the treatment of obesity, diabetes, and cardiovascular
disease [17].
In C. elegans, the fat-5 gene encodes a palmitoyl-CoA
desaturase, while the fat-6 and fat-7 genes encode stear-
oyl-CoA desaturases, and gene knockout strains have been
generated and characterised using phenotypic analysis and
gene expression, the vital staining of fats, the profiling of
total fatty acids by gas chromatography (but not the profil-
ing of intact lipids) [15,18,19]. While the single mutants
displayed no obvious abnormal phenotypes, likely due to
compensation by the other desaturases, the double
mutants showed slow growth and reduced viability at low
temperature, and the triple mutant was lethal unless sup-
plemented with dietary oleic acid [18,19].
However, while providing an important insight into the
consequences of the deletion on the organism, such
approaches have only partially described the variations in
the global metabolism, focusing on changes in the compo-
sition of fatty acids, and not how these changes interact
with other metabolic pathways, or how they influence the
composition of complex lipids found within an organism.
These aspects are crucial to be studied due to the central
role of the Δ9 enzyme and its products in the regulation
of metabolism. Furthermore, questions have been raised as
to which lipid species are stained by commonly used fat
stains in genome wide screens of fat metabolism. In this
study we have investigated the impact of deletion of fat-5,
fat-6 and fat-7 on both global systemic metabolism and,
for the first time, intact lipids by LC-MS. Using a range of
techniques, including gas chromatography mass spectro-
metry (GC-MS) and nuclear magnetic resonance (NMR)
spectroscopy in addition to LC-MS, we aim to demon-
strate that these deletions show marked changes in lipid
composition and place C. elegans in a catabolic state not
just in lipid metabolism but also in terms of the impact on
the TCA cycle and amino acid metabolism, demonstrating
the influence the Δ9 desaturases have on regulating global
metabolism.
Results
To understand the consequences of Δ9 desaturase dele-
tion on the metabolism of the whole organism in
C. elegans, mutants defective in this enzyme were ana-
lysed using a wide range of metabolomic techniques,
that allowed us to characterize both aqueous and lipid
metabolites. We complemented our analysis by visualiz-
ing the fat content by vital and fixative staining meth-
ods. The aim is to integrate the rapid but generic results
of the dyes with the deeper insights into metabolic
changes obtained using the NMR or LC-MS techniques.
As already reported in previous publications [19,20] at
20°C the fat-6;fat-7 double mutant animals display a
greatly reduced fertility and slow growth. These charac-
teristics made the strain unsuitable for our studies, as it
was neither possible to generate a sufficient number of
animals in parallel with the other strains to be analysed,
nor separate the metabolic changes associated with the
genetic modifications per se and the restriction in
growth/development.
Staining of lipid deposits
We hypothesised that animals partially lacking Δ9 desa-
turase activity may have altered lipid content. To address
this, global levels of fat storage in wild type and Δ9 desa-
turase mutants were assessed. The wild type, fat-5, fat-6
and fat-7 mutants, as well as fat-5;fat-6 and fat-5;fat-7
double mutants were stained with both the vital dye Nile
Red and with the fixative dye Oil Red-O, both of which
have previously been used to characterize fat storage in
C. elegans [12,21].
Quantification of Nile Red staining in L4 animals
showed significant decreases in the intensity of staining
for fat-5 (p = 0.0006), fat-6 (p = 0.032) and fat-5;fat-6
(p = 0.004) genotypes (Figure 1A and 1B) compared
with wild type. Using Nile red staining, as previously
reported the fat-6;fat-7 mutant had a more pronounced
reduction in lipid accumulation [19]. However, use of
Nile Red has been criticized recently, suggesting that the
dye could be treated as a xenobiotic by the animal and
partitioned into a degradative compartment [22-24]. The
Oil Red-O assay was performed (Figure 1A), but did not
show any significant difference between the strains
(Figure 1B).
The overall content of fatty acids (Figure 1B), as quan-
tified by GC-FID, decreased in mutants significantly
compared with wild type for all the strains except the
fat-7 mutant. However, the ratio between triglycerides
and phospholipids (Figure 1B), as obtained by LC-MS,
showed no significant differences between wild type and
any of the Δ9 desaturase mutant genotypes, except the
fat-5 mutant: these results indicate that there is genetic
redundancy between the Δ9 desaturases [18,19] and sug-
gest more complex remodelling of the lipid fraction than
a simple decrease in the triglyceride content. Therefore,
these changes were investigated further in these
mutants.
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NMR analysis of aqueous extracts
Proton-NMR spectroscopy was used to profile a range of
aqueous metabolites including amino acids, organic
acids, sugars and metabolites associated with lipid meta-
bolism (Figure 2A, B and Additional file 1: Table S1).
Principal components analysis (PCA) was performed on
the NMR spectra of all the strains to characterise the
major changes in the metabolic profiles (data not shown;
12 PCs, R2 = 85%, Q2 = 54%). However, the first PC
(explaining ~30% of the total variance) revealed differ-
ences between batches of animals. To highlight the meta-
bolic variation due to the Δ9 desaturase knock-out,
Multilevel Simultaneous Component Analysis (MSCA)
was applied to the data set. The Partial Least Squares-
Discriminate Analysis (PLS-DA) model obtained from
the within-batches term of the MSC analysis has 6 latent
variables (by cross-validation, with R2(X) = 56%, R2(Y) =
64%, Q2 = 34%) and separated the mutants according to
genotype (Figure 2C). The co-clustering between the
metabolic profiles of fat-6 (BX106) and fat-7 (BX153)
mutants may be expected as both fat-6 and fat-7 encode
stearoyl-CoA desaturases and they were shown to have
functional redundancy [18]. Clear discrimination was
achieved for the two double mutant strains: fat-5;fat-7
(BX160) has a metabolic profile similar to the single
mutants, while fat-5;fat-6 (BX110) lies in-between the
two single mutants.
Analysis of the loadings plot was used to identify the
metabolites most responsible for this discrimination
(Figure 2D) - succinate (δ 2.42; signifying resonance
identified), alanine (δ 1.48), choline (δ 3.20) and glycero-
phosphocholine (δ 3.26) had increased concentrations in
mutant strains, while branched chain amino acids (δ
0.96-1.05) were increased in the wild type.
Amino Acid analysis of the aqueous extracts
A targeted analysis of amino acids was performed by GC-
MS [25], identifying 22 amino acids (Additional file 1:
Figure 1 Vital and fixative stainings of the Δ9 desaturase mutants. (A) Representative images of the Nile Red-stained worms (upper rows
for each strain) and of the Oil Red-O (lower rows) for the mutant and wild type strains. In each image, anterior is positioned to the left. Scale
bar is 50 μm. (B) Quantification of the Nile-Red staining (n = 12 animals at least per genotype), of the Oil Red-O (n = 20 animals at least per
genotype), of the global fatty acid content as measured by GC-FID (n = 8 replicates at least per genotype) and triglyceride/phospholipid
measurements as obtained by LC-MS (n = 8 animals at least per genotype). The GC-FID data were normalised to the same number of worms in
addition to the added internal standard (in the first column) and normalised for the internal standard and the total mg of protein, as measured
by the Bradford assay for protein content (subsequent column). Data are reported as mean ± standard error of the mean (SEM).
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Figure 2 Analysis of the aqueous phase metabolites in extract of C.elegans. 1H-NMR spectrum (A) between 0 and 5 ppm and (B) between
5 and 9.5 ppm for a selected illustrative sample. Key: 1. Ile; 2. Leu; 3. Val; 4. lactate; 5. Ala; 6. Lys; 7. acetate; 8. Glu; 9. Gln; 10. Met; 11. succinate;
12. Asp; 13. Asn; 14. choline; 15. glucose; 16. Gly; 17. trehalose; 18. GTP; 19. ATP; 20. fumarate; 21. Tyr; 22. His; 23. Phe; 24. Trp; 25 formate. (C)
Score plot showing the clustering pattern according to genotype in the metabolic profiles obtained by NMR spectroscopy. Results from PLS-DA
following the MSCA filter on the NMR spectra of all strains. The black squares represent samples belonging to the wild type strain, the red dots
samples belonging to fat-6 mutant, the blue diamonds fat-7 mutant, the green stars fat-5;fat-7 mutant, the orange triangles fat-5 mutant and the
pink squares fat-5;fat-6 mutant. (D) Loading plot for the score plot in C, shows the metabolites responsible for the discrimination among the
groups: results from PLS-DA following MSCA filter on the NMR spectra of all strains. (E) Score plot of PLS-DA following MSCA filter on the amino
acids analysis of all strains using the Phenomenex EZFaast kit. For the key to symbols see above. (F). Loading plot of PLS-DA following MSCA
filter on the amino acids analysis of all strains.
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Table S2). As for the NMR experiments, a MSC filter was
applied to the amino acid data set, to remove the variabil-
ity due to the batches. The PLS-DA model obtained from
the within-batches term of the MSC analysis had 5 latent
variables by cross validation with a R2(X) = 63%, R2(Y) =
59% and a Q2 = 32% (Figure 2E). This model produced
good separation according to genotype including a nota-
ble distinction between the two single mutants lacking
one of the two stearoyl-CoA desaturases, fat-6 and fat-7.
The loading plots associated with this analysis (Figure
2F) demonstrated an increased concentration of branched
chain amino acids (leucine, isoleucine and valine) was
found in the wildtype, while in the mutants there is a
higher content of ornithine, cystathionine, asparagine and
lysine. The fat-6 mutant was categorized by a particularly
high concentration of alanine. Additional file 1: Table S3
summarises the characteristics of all the models built con-
sidering each mutant strain against the wild type. The list
of the most significant amino acids changes considering
each mutant against the wild type is shown in Additional
file 1: Table S4.
The lipid phase was characterised both by GC-FID
and LC-MS. The first technique allows a characteriza-
tion of the fatty acids present in the samples, without
considering the origin of the fats as they are cleaved
from the original lipid species during the trans-esterifi-
cation. Thus, LC-MS was also used to profile the intact
lipids.
GC-FID analysis of lipid extracts
Using GC-FID analysis of the C. elegans lipid extracts it
was possible to identify straight chain fatty acids,
branched chain fatty acids and cyclopropane fatty acids
(Additional file 1: Table S5). As already reported [18,26],
the nematode is able to synthesize de novo branched
chain fatty acids from branched chain-CoA derived from
leucine, valine and isoleucine. The cyclopropane fatty
acids are synthesized by E. coli and absorbed through the
diet.
In Table 1, the ratios between selected fatty acids
highlighting the activities of the desaturase enzymes are
reported. Considering the single mutants, the ratio
between C16:1 and C16:0 was decreased for the fat-5
mutant, as expected due to the fact that the palmitoyl-
CoA desaturase has been knocked out; the ratio between
C18:1n9 and C18:0 decreased for both fat-6 and fat-7
mutants, as expected for the reduction in expression of
stearoyl-CoA desaturase. However, in the fat-5 mutant
the ratio C18:1n9/C18:0 is significantly increased com-
pared with the wild type (p = 8.76 *10-6), suggesting an
increased production of C18:1n9 to compensate for the
lack of C16:1 and C18:1n7, the most abundant monoun-
saturated fatty acids. The ratios between C20:4n6 and
C20:3n6, in both fat-6 and in fat-7 mutants, and
between C20:3n6 and C18:2n6, in fat-5 mutants, were
also changed as would be expected following the reduc-
tion in concentration of one of the main precursors in
the synthesis of polyunsaturated fatty acids. For the dou-
ble mutants, surprisingly, the ratios were not altered in
the majority of cases compared to the wild type. This
suggests a more complex reorganization of the system
due to the lack of the palmitoyl-CoA desaturase and
one of the stearoyl-CoA desaturase.
PLS-DA was applied to the within-batches term from
MSCA of the GC-FID total fatty acids (FA) data across
all of the strains (Figure 3A; 5 latent variables by cross
validation, with R2 X = 76%, R2Y = 58% and Q2 = 45%).
This model demonstrated good separation among all the
strains: the double mutant fat-5;fat-7 had the most differ-
ent profile. In addition the two single mutants lacking
one of the stearoyl-CoA desaturase genes showed differ-
ences in their fatty acid content.
From an examination of the loadings plot (Figure 3B)
mutant strains had higher concentrations of saturated
FAs, reflecting the reduced capacity to convert them into
monounsaturated FAs. There was a general decrease in
the intensities of the PUFAs. There was also a decrease in
the branched fatty acids to an extent that the ratio
between total content of PUFA and branched fatty acid
(BFA) increased markedly from the wild type to the
mutant strains (PUFA/BFA = 5 ± 4 for wild type, 4.5 ± 0.8
for fat-5, 13 ± 3 for fat-6 mutant (p = 0.021), 11 ± 4 for
Table 1 Relative changes of the desaturase indexes in the fat mutant strains.
fat-6 fat-5 fat-5;fat-6 fat-7 fat-5;fat-7
SCD-16 (16:1/16:0) (fat-5) 0.5 ± 0.1 0.33 ± 0.06
(p = 0.000156)
0.8 ± 0.1 0.4 ± 0.1 0.12 ± 0.03
(p = 0.039839)
SCD-18 (18:1/18:0) (fat-6, fat-7) 0.46 ± 0.07
(p = 0.011178)
0.15 ± 0.05
(p = 8.7E-06)
0.9 ± 0.4 0.55 ± 0.09
(p = 0.063)
1.1 ± 0.2
D5D (20:4(n6)/20:3(n6)) (fat-4) 1. 2 ± 0.1
(p = 0.000076)
0.8 ± 0.1 1.01 ± 0.06 1.2 ± 0.1
(p = 0.00028)
1.1 ± 0.1
(p = 0.0015)
D6D (20:3(n6)/18:2(n6)) (fat-3) 1.1 ± 0.1 0.91 ± 0.08
(p = 0.031)
0.9 ± 0.2 0.9 ± 0.1 0.86 ± 0.08
(p = 0.049)
SCD-16 is the Steroyl-CoA Desaturase (Δ9) specific in converting palmitic acid to palmitoleic; SCD-18 is the Steroyl-CoA Desaturase (Δ9) specific in converting
stearic acid in oleic; D5D is the Δ5 desaturase; D6D is the Δ6 desaturase. In parenthesis the gene expressing the enzyme is indicated. Data are reported as ratio
between the ratio of the mutant and the one of the wild type, in parenthesis t-test results for significant changes are shown.
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Figure 3 Analysis of the lipid phase of the extracts. (A) Score plot of PLS-DA following MSCA filter on the total fatty acid content as
measured by GC-FID analysis of all strains. For the meaning of the symbols see key in Figure 2C. (B) Loading plot of PLS-DA model in A. (C)
Lipid chromatogram for a selected illustrative sample of the lipid fraction obtained by reversed phase Ultra Performance Liquid Chromatography
coupled to high resolution Mass Spectrometry (positive ion mode). Key: PL: PhosphoLipids; TAG: Triacylglycerols. (D) Score plot of PLS-DA
following MSCA filter on the UPLC-MS experiments on the intact lipid phases of all strains. For the meaning of the symbols see the key in Figure
2C. (E). The loading plot of the PLS-DA model in D.
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fat-7 (p = 0.05), 13 ± 1 for fat-5;fat-7 (p = 0.029) and 8.4 ±
0.6 for fat-5;fat-6 (p = 0.0031)).
For both the double mutant fat-5;fat-6 and wild type
there was relatively more C18:1n9 compared with the
other genotypes (Additional file 1: Table S6 displays the
characteristics of the PLS-DA models considering each
mutant against the wild type, while Additional file 1: Table
S7 shows a list of the most significant changes in fatty
acids considering each mutant compared with the wild
type). The fat-5;fat-6 mutant strain produces no fat-5, so
it cannot convert palmitic acid to palmitoleic (the intensity
of palmitoleic was very low in this mutant) and thus,
monounsaturated fats must be produced by fat-7, the only
desaturase that is still functional. In the other double
mutant (fat-5;fat-7) the absence of FAT-7 disrupts the
normal ratio between oleic and stearic acid, despite retain-
ing a functional copy of the highly expressed gene fat-6.
This suggests there may be both redundant and non-
redundant roles for FAT-6 and FAT-7.
LC-MS analysis of lipid extracts
In Figure 3C, a typical chromatogram obtained analysing
the intact lipids is shown. Again a MSCA/PLS-DA
approach was used to produce a model that separated all
the strains (Figure 3D; R2 X = 49%, R2Y = 68% and Q2 =
30%). This model passed cross validation and more robust
models were produced when two-way comparisons were
considered with respect to the wild type strain (Additional
file 1: Table S8). In particular the two single mutants lack-
ing one of the two stearoyl-CoA desaturase genes (fat-6
and fat-7) were characterised by very different lipid pro-
files and contributions to the loadings plots (Figure 3E). A
common feature of most of the mutants, and in particular
the single mutant fat-6, was the higher content of trigly-
cerides containing fatty acids absorbed from the diet (in
particular, TAG(17:0Δ/19:0Δ/17:0Δ); TAG(17:0Δ/16:1/
17:0Δ); TAG(17:0Δ/18:1/17:0Δ); TAG(17:0Δ/18:1/19:0Δ)),
while others (in particular the single mutant fat-5 and the
double mutant fat-5;fat-7) had a higher content of trigly-
cerides containing saturated fatty acids (in particular, TAG
(18:0/16:0/18:0); TAG(16:0/18:0/16:0); TAG(16:0/16:0/
16:0)). Furthermore, decreased content of phosphocho-
line-lipids containing unsaturated fatty acids (PC(36:3); PC
(38:6)) was found in the mutants compared with the wild
type strain.
Gaussian Graphical Models on GC-FID Experiments of the
lipid fraction
The results obtained by the GC-FID experiments of the
lipid fraction were also analysed using Gaussian Graphi-
cal Models (GGM), weighted networks where nodes,
representing the measured entities (fatty acids in this
case), are connected through edges annotated with the
partial correlation coefficient between the two. The
method aims to identify the correlations that remain
between nodes if the effect of all the other variables has
been removed from the contribution.
In Figure 4A, the network obtained considering the 30
highest partial correlation coefficients of all the strains
together is shown. The backbone of the synthesis of the
straight chain fatty acids, from C14:0 to C22:0 is evident.
Interestingly, there are branches from C14:0 and C16:0,
linking either the next saturated fatty acid (catalytically
through elongase) or to the next monounsaturated fatty
acid (catalytically through elongase and Δ9 desaturase).
Other strong partial correlations are between C15:0-ISO
and C17:0-ISO (through the selective enzyme ELO-6) and
C17:0-Delta and C19:0-Delta with C18:3n3 (both the
cyclopropane fatty acids detected come from the diet).
In Figure 4B and 4C the network obtained considering
the 30 highest partial correlation coefficients for each
strain against the wild type are shown. In each case, the
backbone of the fatty acid elongation pathway can be iden-
tified. It is possible to note certain correlation patterns
associated with the deletion of a given gene - for example,
the cluster formed by C15:0-ISO, C17:0-ISO and C18:1n7,
in fat-5 mutants: C18:1n7 is synthesised by the elongation
of C16:1n9, obtained by desaturation from C16:0 by FAT-
5 palmitoyl-CoA desaturase. The correlation structure for
fat-6 and fat-7 mutants are markedly different, even
though the genes both encode a stearoyl-CoA desaturase,
demonstrating their very different roles in regulating fat
metabolism.
Discussion
To date most studies focused on metabolic changes
induced by modifying the expression of desaturases in C.
elegans have used GC-based approaches to profile the
total fatty acids present. In this study we extended this
analysis to also include aqueous metabolism and intact
lipids to demonstrate a profound perturbation in global
metabolism induced by perturbing the expression of the
desaturases. The perturbations detected across the net-
work of metabolism highlights the usefulness of global
profiling tools for functional genomics. The use of LC-MS
to profile intact lipids provides greater detail in terms of
the fatty acid changes when compared with GC alone, and
the profiling of amino acid analysis provides a further
insight into core aqueous metabolism, something which is
often ignored in many studies of fat metabolism in
C. elegans.
The expression profiles of stearoyl-CoA desaturases are
regulated by a large number of transcriptional and envir-
onmental inputs. In turn, the activities of these enzymes
affect a large number of processes in the organism. The
direct effects of knocking-out a desaturase enzyme is to
modulate the ratio of saturated to unsaturated fatty acids,
but this in turns affects membrane fluidity, activates
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Figure 4 Graphical Gaussian Model obtained considering the 30 highest partial correlation coefficients from the results of the GC-MS
experiments on the lipid fraction to measure total fatty acid content. (A) The network calculated considering the fatty acid concentrations
in all the strains. The network was also calculated considering wild type and fat-6 mutant (B) alone, and wild type and fat-7 mutant (C) alone.
The straight lines represent positive partial correlation coefficients between the fatty acids, while dotted lines represent negative partial
correlation coefficients. The intensity of the line is proportional to the intensity of the correlation.
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specific signalling pathways, and influences mobility or
activity of membrane bound proteins. As part of this, reor-
ganisation may happen through feedback mechanisms
involving metabolites as signals, and hence a global meta-
bolomic strategy is needed in order to fully define all of
the perturbations induced across the network of metabo-
lism and not only those in fatty acid synthesis.
The higher content of fatty acids in the wild type strain
compared with the Δ9 desaturase mutants was demon-
strated by both GC-FID and LC-MS analysis, yet it was
not detected by Oil Red-O staining. Previously, the fat
content of these mutant strains has been measured by
coherent anti-Stokes Raman scattering (CARS) [27], show-
ing a 1.4-fold decrease in the expression level of neutral
lipid droplets for the fat-5;fat-6 double mutant. One rea-
son for this discrepancy between the Oil Red-O staining
and other methods is that the Oil Red-O method is typi-
cally not sensitive enough to detect such a variation. The
decrease detected by GC and LC-MS is not only due to a
reduction in the actual synthesis of the lipids, but also due
to an increase in the catabolism of the fatty acids, with
dietary fatty acids representing a larger proportion of the
total fatty acid compliment. This is also supported by the
increase in succinate, which indicates an increase in
acetyl-CoA metabolism via the glyoxylate cycle. A dra-
matic increase in the expression of genes involved in mito-
chondrial and peroxisomal b-oxidation has been reported
in mutants where the desaturases have been knocked out
[19]. In mice, the deletion of SCD-1 leads to a decrease in
the content of TAG and cholesterol esters and down-regu-
lates de novo fatty acid synthesis. Furthermore, the dele-
tion reduces lipid content by enhancing oxidation [28] and
thus, an increase in catabolism following reduced desatur-
ase activity appears to be highly conserved. It has also
been shown that during fasting the concentration of stea-
ric acid is maintained due to a strong fasting-dependent
repression of the fat-7 gene, when peroxisomal and mito-
chondrial fatty acid b-oxidation are selectively stimulated
[29], suggesting a regulatory interaction between fat-7 and
b-oxidation, possibly by sensing the concentration of stea-
ric acid. Moreover, an increase in the fatty-acid-binding
proteins lpd-1-lpd-7 has been observed in the desaturase
knocked-out mutants [19]: these proteins sequester and
transport fatty acids and acyl-CoA esters, facilitating their
intracellular utilization, storage and signalling functions.
An increase in their expression suggests an increment in
the traffic of the fatty acids in the cell and is in agreement
with an increase in their catabolism detected in this study.
However, this is not the only reorganization in the lipid
content of the mutants. The results show a reduction in
some of the phosphocholine derivatives in the mutants,
in particular in those containing unsaturated fatty acids,
suggesting a reorganisation of the cell membrane. This
may be because the cell membranes have a reasonable
amount of tolerance to the inclusion of saturated fatty
acids, and the conservation of PUFAs for specific roles
such as the synthesis of signalling molecules. Indeed,
there is an enhancement in the heat-stress tolerance
when animals are treated with RNAi for fat-6 and fat-7
[30] arising from the increased incorporation of saturated
fatty acids in the membranes. The changes in phospho-
choline metabolism could only be followed in this high
level of detail by the use of LC-MS. The approach detects
the lipids directly and using fragmentation patterns we
can deduce how changes in total fatty acid profiles effect
the different phospholipids found in C.elegans.
The efficient storage of lipids within lipid droplets
appears to be highly dependent on the generation of
MUFAs. Unsaturated FAs, but not saturated FAs, induce
the formation of lipid droplets or increase the size of the
existing lipid droplets. This is confirmed by the fact that
when supplemented with vaccenic acid (18:1n7) the
concentration of TAGs were increased in mutants with
peroxisomal dysfunctions [31]. Furthermore, an impair-
ment in desaturase activity is correlated with a
decreased ability to generate and expand lipid droplets
to facilitate TAG storage. Under conditions where
MUFAs are in short supply to prevent the accumulation
of toxic saturated lipids within the cytoplasm mitochon-
drial and peroxisomal b-oxidation is stimulated [19],
possibly through the action of nhr-49, the C. elegans
homologue of PPARa.
The fact that both BFAs and MUFAs decrease in the
present study further suggests a general increase in the
catabolism of fatty acids, and thus while unsaturated fats
may compensate for a lack of BFAs the reverse is not
necessarily true. Indeed, when the double mutant fat-6;fat-
7 is treated with nhr-64(RNAi) (a gene, whose knock-
down suppresses the low fat phenotype of the double
mutant) an increase in the concentrations of branched
fatty acid was found. This was attributed to a general
increase in fatty acids synthesis [20].
There is an inverse correlation between the concentra-
tion of C17iso in TAGs and fat storage levels [24].
C17iso is proposed to act as a chemical/nutritional indi-
cator of the metabolic state of C. elegans. As this fatty
acid is the final step of a synthesis that is initiated from
the amino acid leucine, the concentration of C17iso may
reflect the concentrations of essential dietary amino
acids and more generally protein and lipid homeostasis
in the organism. Δ9 desaturase-deleted mutants have
both reduced content of branched fatty acids and essen-
tial amino acids.
Previously, the focus of metabolic studies on these
strains has been on the changes in the fatty acid compo-
sition. In the present study, in addition to profiling
intact lipid metabolites and cleaved fatty acids, also a
non-targeted profiling of the aqueous phases was
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performed, demonstrating that the changes associated
with the deletion of the desaturases are not limited to
the lipid fractions but extend to the entire metabolome.
The increase in the concentration of alanine in the
mutants, indicative of increased glycolysis and consump-
tion of amino acids, as well as an increase in succinate
suggesting increased metabolism through the citric acid
cycle are indicative of a general increase in catabolism.
Furthermore, the increased content of branched amino
acids in the wild type compared to the mutants seems
to confirm this higher catabolic state accompanying the
deletions of the Δ9 desaturase genes. These amino acids
are the starting point for the synthesis of the branched
fatty acids, but both branched chain amino acids and
fatty acids decrease in concentration in the mutant, sug-
gesting increased catabolism of both metabolite classes.
The higher content of choline, a precursor of membrane
phospholipids, in the mutants compared to wild type is
another indicator of the lipid reorganization.
There is numerous evidence suggesting that fat-6 and
fat-7 have both redundant and non-redundant functions.
Our results show differences in the behaviour of both the
two single mutants and the two double mutants. The
analysis of the amino acid profiles by GC-MS indicates a
different influence of the two genes on other metabolic
pathways, such as amino acid anabolism and catabolism.
The analysis on the intact lipids also demonstrated an
increase in absorption of cyclopropane fatty acids in the
fat-6 single mutant to compensate the absence of desa-
turation. This strain lacks the most highly expressed Δ9
desaturase. Other strains, instead, show an increase in
the content of saturated fatty acids in the lipids. These
results are confirmed also by the analysis of fatty acids by
GC-FID: there is an increase in the content of C17:0_Δ
in the fat-6 verses wild type model, not present in the
fat-7 verses wild type model. However, without LC-MS it
would have not been possible to follow this remodelling
of the triglycerides.
Conclusions
We have shown that deletion of Δ9 desaturases have pro-
found effects on metabolism in C. elegans that far extend
from the initial reduction in MUFAs. In particular, the
major results obtained by our comprehensive characteri-
zation were that:
i. the mutants had increased accumulation of triglycer-
ides from dietary or saturated fats. However, overall the
total fat content was decreased in the mutants compared
to the wild type indicative of increased catabolism;
ii. a reduction in some phosphocholine derivatives in
the mutants, especially those containing unsaturated
fatty acids, suggest reorganisation of cell membranes.
iii. a general increase in fatty acid and amino acid cat-
abolism in the mutants.
Currently the majority of studies of fat storage in
C. elegans rely on whole animal staining, gas chromato-
graphy analysis of total fatty acids or thin layer chroma-
tography of lipid classes. However, the propagation of
the changes into a wide range of metabolic pathways
highlighting the usefulness of global profiling tools for
functional genomics.
Methods
Culture of nematodes
C. elegans were grown under standard conditions on
Nematode Growth Media (NGM) with HB101 [32] as
food source, at 20°C. The wild-type strain used was Bris-
tol N2 [33]. Mutant strains were obtained from the Cae-
norhabditis Genetics Center, University of Minnesota,
Twin Cities, MN and included: BX107 fat-5(tm420) V;
BX106 fat-6(tm331) IV; BX153 fat-7(wa36) V; BX110
fat-7(wa36) V fat-5(tm420) V (referred to as fat-5;fat-7
in the text); BX160 fat-6(tm331) IV;fat-5(tm420) V
refered to as fat-5;fat-6); and BX156 fat-6(tm331) IV;fat-
7(wa36) V. Mutations were verified using PCR and
DNA sequencing prior to starting experiments (details
of primers available on request). For each experiment,
early embryos were isolated by alkaline hypochlorite
treatment [33] and plated after synchronisation on
NGM plates seeded with bacteria. For each biological
replicate, ~8000 animals were harvested, washed and
stored at -80°C until extraction. Eight samples were
grown for each strain.
Nile Red and Oil Red-O staining and quantification
Nile Red staining was performed as described previously
[12]. Images were acquired on an Axio Imager A1
Microscope (Zeiss) fitted with a CCD camera (Hama-
matsu Orca ER 12 bit) and OpenLab(Version 4.0.4) pro-
gramme, using identical settings and exposure times to
allow direct comparisons. Reported Nile Red intensities
were quantified using ImageJ software (NIH) on 8-10
animals of each genotype randomly selected. Each
experiment was repeated at least three times.
Oil Red-O staining was performed as described pre-
viously [21]. Briefly, young adult animals were washed
from plates into 120 μL of PBS, pH8, to which an equal
volume of 2× MRWB buffer containing 2% paraformal-
dehyde was added. Animals were taken through three
freeze-thaw cycles between a dry-ice/ethanol bath and
warm running tap water and fixed for 1 hour at 4°C.
They were then washed in PBS to remove PFA, and
incubated in 60% isopropanol to dehydrate, and then in
a 60% Oil Red-O stain solution. Images were acquired
on an Axio Imager A1 Microscope fitted with a QICAM
1394 CCD camera using identical settings to keep the
background illumination constant across different
samples.
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For the quantification, the image was imported in
ImageJ and thresholded to identify the worm area. In
the original image, the averaged intensity values of the
green and blue channels were subtracted from the red
channel, and the total intensity calculated subtracting
the mean intensity of background from the mean inten-
sity across the picture. The obtained value was normal-
ized by the area of the animals within the field of view
of the image.
Extraction procedure for metabolites
Metabolites from whole nematodes were extracted using a
methanol-chloroform procedure. 600 μl of methanol-
chloroform (2:1 v:v) was added to the frozen nematodes
and samples were sonicated for 15 min. 200 μl each of
chloroform and water were added, the samples centrifuged
and the aqueous layer separated from the lipid one. The
procedure was repeated twice. The aqueous layer was
dried overnight in an evacuated centrifuge, while the lipid
fraction was dried overnight in the fumehood.
Analysis of aqueous extracts
NMR spectroscopy: The dried extracts were rehydrated in
550 μl D2O, containing 0.05 mM (sodium-3-(tri-methylsi-
lyl)-2,2,3,3-tetradeuteriopropionate (TSP) (Cambridge Iso-
tope Laboratories, MA, USA) as an internal standard. The
samples were analysed using an AVANCE II+ NMR spec-
trometer operating at 500.13 MHz for the1H frequency
(Bruker, Germany) using a 5 mm TXI probe. Spectra were
collected using a solvent suppression pulse sequence
based on a one-dimensional NOESY pulse sequence to
saturate the residual1H water signal (relaxation delay =
2 s, t1 increment = 3 us, mixing time = 150 ms, solvent
presaturation applied during the relaxation time and the
mixing time). One hundred and ninety-six transients were
collected into 16 K data points over a spectral width of 12
ppm at 27°C. In addition, representative samples of nema-
todes were also examined by two-dimensional spectro-
scopy, including COSY (COrrelation SpectroscopY), in
conjunction with reference to previous literature and data-
bases [34-36] and the Chenomx spectral database con-
tained in Chenomix NMR Suite 5.0 (Chenomx, Alberta,
Canada)) for spectral assignment.
GC-MS: The samples analysed by NMR were dried over-
night in an evacuated centrifuge and rehydrated in 150 μl
of water. 100 μl were used for the analysis by the EZ:faast
Free (Physiological) Amino Acid Analysis by GC-MS kit
(Phenomenex, USA). The samples were analysed accord-
ing to the procedure described by the manufacturer.
Analysis of lipid extracts
Lipid extracts were dissolved in 200 μl of chloroform/
methanol (1:1 v/v): half was used for GC-FID analysis of
total fatty acids and half for LC-MS analysis of intact
lipids. For the GC-FID analysis 50 μl of D-25 trideca-
noic acid (200 μM in chloroform), 650 μl of chloro-
form/methanol (1:1 v/v) and 250 μl BF3/methanol
(Sigma-Aldrich) was added to the extract and the vials
were incubated at 80°C for 90 min. 500 μl H2O and
1 ml hexane were added and each vial vortex mixed.
The organic layer was evaporated to dryness before
reconstitution in 100 μl hexane for analysis. The deriva-
tised organic metabolites were injected in a Focus GC
and the column eluent was introduced into a flame-ioni-
zation detector (FID, Thermo Electron Corporation).
The column used was ZB-WAX (Phenomenex; 30 m ×
0.25 mm ID × 0.25 μm; 100% polyethylene glycol). The
initial column temperature was 60°C and was held for
2 min. This was increased by 15°C min_1 to 150°C then
increased at a rate of 3°C min_1 to 230°C. This final
temperature was held for 10 minutes. Peaks were
assigned using Food Industry FAME Mix (Restek 6098)
and Bacterial Acid Methyl Ester (BAME) Mix solution
(Supelco 47080).
For LC-MS 5 μl of each sample was analysed on a
Waters Q-Tof Ultima mass spectrometer combined with
an Acquity Ultra Performance LC (UPLC). The sample
was injected onto a 1.7 μm bridged ethyl hybrid C8 col-
umn (2.1 × 100 mm; Waters Corporation) held at 65°C.
The binary solvent system (flow rate 0.200 ml/min)
included A. HPLC grade water (1% 1 M NH4Ac, 0.1%
HCOOH) and B. LC/MS grade acetonitrile/isopropanol
5:2 (1% 1 M NH4Ac, 0.1% HCOOH). The gradient started
from 65% A/35% B, reached 100% B in 6 min and
remained there for the next 7 min. The data was collected
over the mass range of m/z 100-1400 with a scan duration
of 0.5 sec and an interscan delay of 0.1 s. The source tem-
perature was set at 100°C and nitrogen was used as deso-
lvation gas (600 L/h) at 300°C. The voltages of the
sampling cone and capillary were 40 V and 3 kV, respec-
tively and collision energy 5 V. Reserpine (50 μg/L) was
used as the lock spray reference compound (10 μl/min;
10 sec scan frequency).
To assign the lipid species present, a representative
sample for each strain was analysed by tandem mass
spectrometry (MS/MS). MS/MS runs were performed
using ESI+ mode and collision energies of 18, 20, 24,
30 V and a mass range of 80 to 1,100 m/z. Other condi-
tions were as described above.
Data processing
NMR spectra were processed using ACD one-dimen-
sional NMR processor (vers. 8, ACD, Toronto, Canada).
Free induction decays were Fourier transformed follow-
ing multiplication by a line broadening of 1 Hz, and
referenced to TSP at 0.0 ppm. Spectra were phased and
baseline corrected manually. Each spectrum was inte-
grated using 0.01 ppm integral regions between 0.5 and
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4.5, and 5.5-9.5 ppm. Each spectral region was normal-
ised to a total integral value of 1000. GC-FID chromato-
grams were analysed using Xcalibur, version 2.0
(Thermo Fisher), integrating each peak individually.
Each integrated peak was normalised so that the total
sum of peaks was set to 1000. LC-MS chromatograms
were analysed using Micromass Markerlynx Applica-
tions Manager Version 4.1 (Waters Corporation). The
ion intensities for each lipid identified were normalized
so that the sum of the peak within each sample was set
to 1000. Furthermore, the regions corresponding to the
different classes of lipids were integrated from each
chromatogram, to quantify them.
Multivariate analysis of metabolic profiles
Each set of metabolic profiles obtained were analysed by
multivariate analysis. Datasets were imported into
SIMCA-P 11.0 (Umetrics, Umea˚, Sweden) for proces-
sing using PCA and PLS-DA (a regression extension of
PCA used for supervised classification). 1H NMR data
were Pareto scaled, in which each variable was centred
and multiplied by 1/(Sk)
1/2 where Sk is the standard
deviation of the variable. GC-MS data were scaled to
unit variance by dividing each variable by 1/(Sk). LC-MS
data were Pareto scaled.
In addition, a Multilevel Simultaneous Component
Analysis (MSCA) [37] was applied to the non-normal-
ized data set. MSCA is a combination of Analysis-of-
variance and Simultaneous Component Analysis and it
enables analysis of metabolomic studies with an experi-
mental design. It takes into account the multilevel struc-
ture in the data allowing a separate analysis and
interpretation of the variation sources induced by the
different factors in the experimental design. It was per-
formed using Matlab (The MathWorks) with the rou-
tines available from van Velzen et al., 2008 http://www.
bdagroup.nl/content/Downloads/software/software.php.
The data set was split in a between-batches term (biolo-
gical variation) and within-batches term (genetic varia-
tion). The batches were defined as follow: one contained
N2 (wildtype), BX106 (fat-6), BX153 (fat-7) and BX160
(fat-5;fat-7); one N2 (wildtype) and BX107 (fat-5); and
the third N2 (wildtype) and BX110 (fat-5;fat-6). The
within-batches term was imported into SIMCA-P, Par-
eto (NMR and GC-FID data) or unit variance (GC-FID)
scaled and analysed by PLS-DA.
Gaussian Graphical Models of fatty acids analysed by GC-
FID
The fatty acid peaks identified in the GC-FID chromato-
grams were normalised to the internal standard,
imported into R and analysed by Gaussian Graphical
Models (GGM), using GeneNet [[38]; http://strimmer-
lab.org/software/genenet/].
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